COST EFFECTIVENESS OF BOCEPREVIR PLUS PEGINTERFERON ALPHA AND RIBAVIRIN VERSUS PEGINTERFERON ALFA PLUS RIBAVIRIN IN THE TREATMENT OF CHRONIC HEPATITIS C (CHC) IN PREVIOUSLY UNTREATED GENOTYPE I PATIENTS

被引：0
|
作者：
Fonseca, M. [1 ]
Tannus, G. [1 ]
Parisi, E.
机构：
[1] Univ Fed Sao Paulo, Axia Bio Consulting, Sao Paulo, Brazil
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 04期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A139 / A139
页数：1
相关论文
共 50 条
  • [1] COST EFFECTIVENESS OF BOCEPREVIR PLUS PEGINTERFERON ALPHA AND RIBAVIRIN VERSUS TELAPREVIR PLUS PEGINTERFERON ALFA AND RIBAVIRIN IN THE TREATMENT OF CHRONIC HEPATITIS C (CHC) IN PREVIOUSLY UNTREATED GENOTYPE I PATIENTS
    Fonseca, M.
    Garran, V
    Araujo, G. T.
    VALUE IN HEALTH, 2012, 15 (07) : A328 - A328
  • [2] COST EFFECTIVENESS OF THE COMBINATION OF BOCEPREVIR PLUS PEGINTERFERON ALPHA AND RIBAVIRIN VERSUS TELAPREVIR PLUS PEGINTERFERON ALFA AND RIBAVIRIN IN THE RETREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C VIRUS GENOTYPE I INFECTION
    Fonseca, M.
    Garran, V
    Araujo, G. T.
    VALUE IN HEALTH, 2012, 15 (07) : A329 - A329
  • [3] Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia
    Isakov, Vasily
    Nikitin, Igor
    Chulanov, Vladimir
    Ogurtsov, Pavel
    Lukyanova, Ekaterina
    Long, Jianmin
    Wah, Janice
    Helmond, Frans A.
    WORLD JOURNAL OF HEPATOLOGY, 2016, 8 (06) : 331 - 339
  • [4] Ribavirin dose reduction versus erythropoietin for anemia management in previously untreated patients with chronic hepatitis C receiving boceprevir plus peginterferon/ribavirin
    Sulkowski, Mark
    Poordad, Fred
    Lawitz, E.
    Reddy, K. R.
    Afdhal, N. H.
    Hezode, Christophe
    Zeuzem, Stefan
    Lee, Samuel
    Luis Calleja, Jose
    Brown, Robert S.
    Craxi, Antonio
    Wedemeyer, Heiner
    Deng, W.
    Koury, Kenneth
    Boparai, Navdeep
    Pedicone, Lisa
    Burroughs, Margaret
    Wahl, J.
    Brass, Clifford A.
    Albrecht, Janice K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 16 - 16
  • [5] Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia
    Vasily Isakov
    Igor Nikitin
    Vladimir Chulanov
    Pavel Ogurtsov
    Ekaterina Lukyanova
    Jianmin Long
    Janice Wahl
    Frans A Helmond
    the P08160 trial Investigators
    World Journal of Hepatology, 2016, (06) : 331 - 339
  • [6] Treatment persistence in and cost of therapy for patients with chronic hepatitis C: Peginterferon alfa-2a plus ribavirin versus peginterferon alfa-2b plus ribavirin
    Brixner, Diana I.
    Ye, Xin
    Chu, Teng-Chiao
    Blumentals, William A.
    Hassanein, Tarek I.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (24) : 2171 - 2178
  • [7] Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C
    Hauser, Goran
    Awad, Tahany
    Brok, Jesper
    Thorlund, Kristian
    Stimac, Davor
    Mabrouk, Mahasen
    Gluud, Christian
    Gluud, Lise Lotte
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (02):
  • [8] Randomized trial of asunaprevir plus peginterferon alfa and ribavirin for previously untreated genotype 1 or 4 chronic hepatitis C
    Bronowicki, Jean-Pierre
    Ratziu, Vlad
    Gadano, Adrian
    Thuluvath, Paul J.
    Bessone, Fernando
    Martorell, Claudia T.
    Pol, Stanislas
    Terg, Ruben
    Younes, Ziad
    He, Bing
    Eley, Timothy
    Cohen, David
    Yu, Fei
    Hernandez, Dennis
    McPhee, Fiona
    Mendez, Patricia
    Hughes, Eric
    JOURNAL OF HEPATOLOGY, 2014, 61 (06) : 1220 - 1227
  • [9] HCV SPRINT-1: BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN FOR TREATMENT OF GENOTYPE 1 CHRONIC HEPATITIS C IN PREVIOUSLY UNTREATED PATIENTS
    Kwo, Paul
    Lawitz, Eric J.
    McCone, Jonathan
    Schiff, Eugene R.
    Vierling, John M.
    Pound, David
    Davis, Mitchell
    Galati, Joseph S.
    Gordon, Stuart C.
    Ravendhran, Natarajan
    Rossaro, Lorenzo
    Anderson, Frank H.
    Jacobson, Ira M.
    Rubin, Raymond
    Koury, Kenneth
    Chaudhri, Eirum I.
    Albrecht, Janice K.
    HEPATOLOGY, 2008, 48 (04) : 1027A - 1027A
  • [10] A randomized trial comparing ribavirin dose reduction versus erythropoietin for anaemia management in previously untreated patients with chronic hepatitis c receiving boceprevir plus peginterferon/ribavirin
    Pedicone, Lisa
    Poordad, Fred
    Lawitz, Eric
    Reddy, Rajender K.
    Afdhal, Nezam
    Hezode, Christophe
    Zeuzem, Stefan
    Lee, Samuel S.
    Luis Calleja, Jose
    Brown, Robert S.
    Craxi, Antonio
    Wedemeyer, Heiner
    Deng, Weiping
    Koury, Kenneth J.
    Burroughs, Margaret
    Wahl, Janice
    Brass, Clifford A.
    Albrecht, Janice K.
    Sulkowski, Mark S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 174 - 175
12345